GSA CAPITAL PARTNERS LLP - PROTALIX BIOTHERAPEUTICS INC ownership

PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 33 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.25 and the average weighting 0.0%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of PROTALIX BIOTHERAPEUTICS INC
ValueSharesWeighting
Q3 2023$825
-95.9%
496,781
+1925.4%
0.07%
+2266.7%
Q4 2021$20,000
-94.1%
24,527
-90.4%
0.00%
-91.4%
Q3 2021$339,000
+841.7%
254,871
+2438.1%
0.04%
+483.3%
Q4 2020$36,00010,0420.01%
Other shareholders
PROTALIX BIOTHERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Burrage Capital Management LLC 2,470,332$8,967,0006.83%
Psagot Value Holdings Ltd. 470,255$1,707,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 212,591$772,0000.02%
UBS OCONNOR LLC 150,000$544,000,0000.01%
GSA CAPITAL PARTNERS LLP 10,042$36,0000.01%
Renaissance Technologies 488,634$1,774,0000.00%
Squarepoint Ops LLC 22,068$80,0000.00%
BANK OF AMERICA CORP /DE/ 222$1,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 50,280$183,0000.00%
View complete list of PROTALIX BIOTHERAPEUTICS INC shareholders